| 000 | 01586 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514063027.0 | ||
| 264 | 0 | _c20030725 | |
| 008 | 200307s 0 0 eng d | ||
| 022 | _a1522-8002 | ||
| 024 | 7 |
_a10.1016/s1476-5586(03)80012-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHassenbusch, Samuel J | |
| 245 | 0 | 0 |
_aStereotactic injection of DTI-015 into recurrent malignant gliomas: phase I/II trial. _h[electronic resource] |
| 260 |
_bNeoplasia (New York, N.Y.) _c |
||
| 300 |
_a9-16 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadministration & dosage |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCarmustine _xadministration & dosage |
| 650 | 0 | 4 | _aEthanol |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlioma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intralesional |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMaximum Tolerated Dose |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 | _aStereotaxic Techniques |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aNardone, Emilio M | |
| 700 | 1 | _aLevin, Victor A | |
| 700 | 1 | _aLeeds, Norman | |
| 700 | 1 | _aPietronigro, Dennis | |
| 773 | 0 |
_tNeoplasia (New York, N.Y.) _gvol. 5 _gno. 1 _gp. 9-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1476-5586(03)80012-x _zAvailable from publisher's website |
| 999 |
_c12453209 _d12453209 |
||